WOLFGANG WINKELMAYER to Methylenetetrahydrofolate Reductase (NADPH2)
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Methylenetetrahydrofolate Reductase (NADPH2).
Connection Strength
0.555
-
Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients. Kidney Int. 2005 Dec; 68(6):2857-62.
Score: 0.252
-
Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients. Kidney Int. 2005 May; 67(5):1980-5.
Score: 0.242
-
Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease. Expert Opin Investig Drugs. 2000 Nov; 9(11):2637-51.
Score: 0.044
-
Genetic aspects of hyperhomocysteinemia in chronic kidney disease. Semin Nephrol. 2006 Jan; 26(1):8-13.
Score: 0.016